Research Outcomes

Summary:

The development of translational nanomedicine increasingly depends on simple yet effective nanoscale engineering strategies for controlling biological outcomes. Among them, supramolecular assembly provides a powerful approach, enabling functional nanostructures to form spontaneously through non-covalent interactions. Current design strategies primarily rely on modulating static physicochemical properties, including particle size, shape, and composition. However, biological environments are dynamic by nature, meaning that nanomedicines with similar static properties can exhibit markedly different functional outcomes depending on how they respond to in vivo conditions. To address this challenge, increasing efforts have focused on incorporating tunable supramolecular dynamics through the modulation of intermolecular interactions. Despite these advances, a general framework for connecting dynamic behavior to therapeutic functions remains underdeveloped. In this perspective, we present a new framework for programming supramolecular dynamics, grounded in dynamic engagement with endogenous biomolecules, adaptive reorganization, kinetic stabilization, and structural persistence. We discuss how tunable supramolecular dynamics can regulate the balance between adaptive interactions with biological systems and resistance to physiological perturbations, thus enabling spatiotemporal control of therapeutic outcomes. We propose supramolecular dynamics as a complementary design axis for translational nanomedicine, adding a dynamic dimension to physicochemical design principles and enabling more rational development across diverse therapeutic applications and functional regimes.

https://doi.org/10.1039/d6pm00300a